Differential Reactivity of anti-hepatitis C Virus Screening Assays in Patients With Waning Antibodies

References

• Shepard CW , FinelliL, AlterMJ. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis., 5(9), 558–567 (2005).
   PubMed Web of Science ®Google Scholar
• Grebely J , DoreGJ. What is killing people with hepatitis C virus infection?Semin. Liver Dis., 31(4), 331–339 (2011).
   PubMed Web of Science ®Google Scholar
• Perz JF , ArmstrongGL, FarringtonLA, HutinYJ, BellBP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol., 45(4), 529–538 (2006).
   PubMed Web of Science ®Google Scholar
• van der Meer AJ , VeldtBJ, FeldJJet al. Association between sustained viro-logical response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA, 308(24), 2584–2593 (2012).
   PubMed Web of Science ®Google Scholar
• Guadagnino V , StroffoliniT, RapicettaMet al. Prevalence, risk factors and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in Southern Italy. Hepatology, 26(4), 1006–1011 (1997).
   PubMed Web of Science ®Google Scholar
• Rendina D , VigoritaE, BonavoltaRet al. HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. Eur. J. Epidemiol., 17(9), 801–807 (2001).
   PubMed Web of Science ®Google Scholar
• Guadagnino V , StroffoliniT, CaroleoBet al. Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig. Liver Dis., 45(5), 403–407 (2013).
   PubMedGoogle Scholar
• Petruzziello A , CoppolaN, DiodatoAMet al. Age and gender distribution of hepatitis C virus genotypes in the metropolitan area of Naples. Intervirology, 56(3), 206–212 (2013).
   PubMed Web of Science ®Google Scholar
• Sagnelli E , StroffoliniT, SagnelliCet al. Epidemiological and clinical scenario of chronic liver diseases in Italy: data from a multicenter nationwide survey. Dig. Liver Dis., 48(9), 1066–1071 (2016).
   PubMedGoogle Scholar
• Morisco F , LopertoI, StroffoliniTet al. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: tail of a cohort infected in past decades. J. Med. Virol., 89(2), 291–297 (2017).
   PubMed Web of Science ®Google Scholar
• Colin C , LanoirD, TouzetSet al. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J. Viral Hepat., 8(2), 87–95 (2001).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC) . Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb. Mortal Wkly Rep., 62(18), 362–365 (2013).
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver . EASL clinical practice guidelines: management of hepatitis C virus infection. J Hepatol., 60(2), 392–420 (2014).
   PubMed Web of Science ®Google Scholar
• Medici MC , ChezziC, DeConto Fet al. Evolving strategy for HCV testing in an Italian tertiary care hospital. J. Clin. Virol., 77, 92–98 (2016).
   PubMed Web of Science ®Google Scholar
• Choi MS , LeeK, HongYJ, SongEY, KimDS, SongJ. The role of the signal-to-cut off ratio in automated anti-HCV chemiluminescent immunoassays by referring to the nucleic acid amplification test and the recombinant immunoblot assay. Ann. Lab. Med., 38(5), 466–472 (2018).
   PubMed Web of Science ®Google Scholar
• Makuria AT , RaghuramanS, BurbeloPDet al. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling. Transfusion, 52(9), 1940–1948 (2012).
   PubMed Web of Science ®Google Scholar
• Rafik M , BakrS, SolimanDet al. Characterization of differential antibody production against hepatitis C virus in different HCV infection status. Virol. J., 13, 116 (2016).
   PubMed Web of Science ®Google Scholar
• Vallefuoco L , AdenAbdi F, SorrentinoRet al. Evaluation of the siemens HIV antigen-antibody immunoassay. Intervirology, 57(2), 106–111 (2014).
   PubMed Web of Science ®Google Scholar
• Fletcher GJ , RaghavendranA, SivakumarJ, SamuelP, AbrahamP. Diagnostic reliability of Architect anti-HCV assay: experience of a tertiary care hospital in India. J. Clin. Lab. Anal., 32(2), doi:10.1002/jcla.22245 (2018).
   PubMed Web of Science ®Google Scholar
• Barrett S , GohJ, CoughlanBet al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut, 49(3), 423–430 (2001).
   PubMed Web of Science ®Google Scholar
• Mazzeo C , AzzaroliF, GiovanelliSet al. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut, 52(7), 1030–1034 (2003).
   PubMed Web of Science ®Google Scholar
• Raghuraman S , ParkH, OsburnWOet al. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J. Infect. Dis., 205(5), 763–771 (2012).
   PubMed Web of Science ®Google Scholar
• Bulteel N , ParthaSarathy P, ForrestEet al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J. Hepatol., 65(2), 266–272 (2016).
   PubMed Web of Science ®Google Scholar
• Fried MW , ShiffmanML, ReddyKRet al. Peg interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med., 347(13), 975–982 (2002).
   PubMed Web of Science ®Google Scholar
• Falade-Nwulia O , Suarez-CuervoC, NelsonDRet al. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann. Intern. Med., 166(9), 637–648 (2017).
   PubMed Web of Science ®Google Scholar
• Tagny CT , MbanyaD, MurphyELet al. Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. J. Virol. Methods, 199, 119–123 (2014)
   PubMed Web of Science ®Google Scholar
• Esteban JI , van HeldenJ, AlborinoFet al. Multicenter evaluation of the Elecsys® Anti-HCV II assay for the diagnosis of hepatitis C virus infection. J. Med. Virol., 85(8), 1362–1368 (2013).
   PubMed Web of Science ®Google Scholar
• Alborino F , BurighelA, TillerF Wet al. Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Med. Microbiol. Immunol., 200(2), 77–83 (2011).
   PubMed Web of Science ®Google Scholar
• Kim S , KimJH, YoonSet al. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J. Clin. Microbiol., 46(12), 3919–3923 (2008).
   PubMed Web of Science ®Google Scholar
• Yoo SJ , WangLL, NingHCet al. Evaluation of the Elecsys(®) Anti-HCV II assay for routine hepatitis C virus screening of different Asian Pacific populations and detection of early infection. J. Clin. Virol., 64, 20–27 (2015).
   PubMed Web of Science ®Google Scholar
• Pan J , LiX, HeGet al. Reflex threshold of signal-to-cut-off ratios of the Elecsys® Anti-HCV II anti-HCV II assay for hepatitis C virus infection. J. Infect. Dev. Ctries, 10(9), 1031–1034 (2016).
   PubMed Web of Science ®Google Scholar